Maybe it has something to do with the strength of the Euro -- or maybe it has something to do with a patient's right to know. And just maybe things are beginning to change.
Have a look at this new article (from the Journal of Life Sciences) on how the EU is pondering changing what's allowable vis-a-vis what they call "Information to Patients" and we in the US call "Direct to Consumer Communications:
www.tjols.com/article-640.html
Bottom line -- knowledge is power.
Have a look at this new article (from the Journal of Life Sciences) on how the EU is pondering changing what's allowable vis-a-vis what they call "Information to Patients" and we in the US call "Direct to Consumer Communications:
www.tjols.com/article-640.html
Bottom line -- knowledge is power.
